Tri Locum Partners’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-214,661
Closed -$2.27M 94
2022
Q3
$2.27M Sell
214,661
-919,747
-81% -$9.77M 0.62% 34
2022
Q2
$10.5M Buy
1,134,408
+124,793
+12% +$1.02M 4.29% 8
2022
Q1
$6.95M Buy
1,009,615
+33,682
+3% +$217K 2.71% 20
2021
Q4
$7.86M Buy
975,933
+2,936
+0.3% +$19.5K 3.09% 15
2021
Q3
$5.97M Buy
972,997
+597,477
+159% +$2.27M 2.37% 18
2021
Q2
$1.17M Sell
375,520
-4,717
-1% -$18K 0.38% 28
2021
Q1
$1.46M Buy
+380,237
New +$1.44M 0.36% 29

Other funds holding BLU

Tri Locum Partners's BLU Position: Q4 2022 in Review

Tri Locum Partners sold out of BELLUS Health Inc. (BLU) in Q4 2022, closing a stake of 214,661 shares — an estimated $2.27M sold.

Tri Locum Partners first reported a position in BLU in Q1 2021 and held it in 7 quarters. The position peaked at $10.5M in Q2 2022. 121 funds tracked by Wall St. Rank hold BLU as of Q4 2022.

  • Tri Locum Partners reported no remaining BELLUS Health Inc. position as of Q4 2022 after selling out during the quarter.
  • Tri Locum Partners sold 214,661 BELLUS Health Inc. shares in Q4 2022, an estimated $2.27M.
  • Tri Locum Partners first reported a position in BELLUS Health Inc. in Q1 2021 and held it in 7 quarters.
  • Tri Locum Partners's BELLUS Health Inc. position peaked at $10.5M in Q2 2022.
  • 121 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2022.

Based on Tri Locum Partners's 13F filing for Q4 2022, filed 14 Feb 2023.